Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCisplatinCombined Modality TherapyDoxorubicinCyclophosphamideApoptosisTreatment OutcomeEtoposideNeoadjuvant TherapyBreast NeoplasmsDisease-Free SurvivalNeoplasm StagingSurvival AnalysisApoptosis Regulatory ProteinsLung NeoplasmsCaspasesPrognosisSurvival RateCaspase 3Drug Administration ScheduleCell Line, TumorProto-Oncogene Proteins c-bcl-2PaclitaxelMethotrexateDrug Resistance, NeoplasmCarboplatinInhibitor of Apoptosis ProteinsVinblastineInduction ChemotherapyNeoplasmsTaxoidsNeoplasm Recurrence, LocalIfosfamideAntimetabolites, AntineoplasticAntineoplastic Agents, PhytogenicTime FactorsBleomycinDeoxycytidineOrganoplatinum CompoundsCell SurvivalDNA Fragmentationbcl-2-Associated X ProteinAntineoplastic Agents, AlkylatingDose-Response Relationship, DrugCytarabineCarcinoma, Non-Small-Cell LungOvarian NeoplasmsAnthracyclinesIn Situ Nick-End LabelingAdenocarcinomaX-Linked Inhibitor of Apoptosis ProteinChemotherapy, Cancer, Regional PerfusionTumor Suppressor Protein p53Neoplasm MetastasisSalvage TherapyFollow-Up StudiesAntibiotics, AntineoplasticTumor Cells, CulturedTesticular NeoplasmsSignal TransductionColorectal NeoplasmsNeutropeniaLymphoma, Non-HodgkinVomitingTransplantation, AutologousNauseaHodgkin DiseaseCamptothecinRadiotherapy, AdjuvantApoptosis Inducing FactorRadiotherapyCell ProliferationCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 9Liver NeoplasmsOsteosarcomaDacarbazineBrain NeoplasmsCaspase InhibitorsBone NeoplasmsClinical Trials as TopicGranulocyte Colony-Stimulating FactorProspective StudiesCarmustineNeoplasms, Germ Cell and EmbryonalCaspase 8MitochondriaKaplan-Meier EstimateLomustineMitomycinTumor Markers, BiologicalPlatinum CompoundsStomach NeoplasmsFlow CytometryEnzyme ActivationFas Ligand ProteinMelphalanCells, Cultured